Deepak Chemtex Ltd reported a decline in financial performance for FY 2025-26, with consolidated profit after tax falling to Rs 8.25 crore from Rs 12.36 crore in the previous year. The company announced its 29th Annual General Meeting scheduled for September 21, 2026, where shareholders will vote on key management re-appointments and a Rs 50 crore related-party transaction limit with its subsidiary, DCPL Speciality Chemicals. While earnings contracted, management highlighted the expansion of its manufacturing capacity via Unit No. 3 and the launch of a new US-based business entity, Atlas Tints.
Deepak Chemtex FY26 Profit Declines to Rs 8.25 Crore
Consolidated Profit After Tax stands at Rs 8.25 crore for FY26 compared to Rs 12.36 crore in FY25.
Standalone Revenue from Operations dipped to Rs 53.50 crore from Rs 68.00 crore in the previous fiscal.
Reader Takeaway: Expansion into new US markets and manufacturing unit commissioning offer growth potential despite current profit headwinds.
What just happened
Deepak Chemtex has released its integrated annual report for FY 2025-26, detailing a contraction in financial performance across both standalone and consolidated metrics. The company also announced its 29th Annual General Meeting (AGM) to be held via video conferencing on September 21, 2026. Board proposals include the re-appointment of Chairman and Managing Director Saurabh Deepak Arora and Whole-time Director Trishla Baid Arora for three-year terms starting July 2026.
Why this matters
The decline in profitability highlights operational challenges faced by the company over the past fiscal year. Investors must now assess whether the investment in the new 'DCPL Speciality Chemicals Unit No. 3' and the entry into the US market via 'Atlas Tints' can successfully turnaround financial performance and drive future margins.
What changes now
The board has opted not to recommend a dividend for FY 2025-26, focusing instead on internal capital allocation and expansion. Shareholders will be asked to approve material related-party transactions with DCPL Speciality Chemicals Private Limited, capped at Rs 50 crore to support ongoing operations.
Context metrics (FY 2025-26)
- Consolidated Revenue: Rs 67.64 crore (vs Rs 79.45 crore in FY25)
- Standalone Profit: Rs 6.59 crore (vs Rs 10.07 crore in FY25)
What to track next
Watch for the successful commissioning of the Unit No. 3 manufacturing facility and the initial market uptake of the five new products planned for production. Additionally, monitor the performance of the new US entity, Atlas Tints, to gauge its contribution to long-term international revenue growth.